Skip to main content
PepStack
Hormone · Profile

Nerve Growth Factor

NGF · Beta-NGF

Growth FactorsApproved
MW
325.27g/mol
Formula
C11H19NO10

Nerve Growth Factor (NGF) is a neurotrophin primarily produced in the nervous system and reproductive tissues, playing a crucial role in neuronal survival, differentiation, and function. Researchers primarily study NGF for its potential applications in neuroregeneration and its influence on various physiological processes, including immune responses and reproductive functions. Key findings indicate that NGF facilitates sensory innervation, which can modulate inflammation and promote tissue repair, while also demonstrating significant roles in reproductive physiology across different species, such as inducing ovulation in camelids. Current research continues to explore the multifaceted roles of NGF, particularly its interactions with mesenchymal stem cells and its therapeutic implications in ocular and degenerative diseases. Clinical evidence indicates that NGF may offer promising avenues for addressing challenging medical conditions, highlighting its relevance in both basic and applied biomedical research.

Overview

Übersicht

Nerve Growth Factor (NGF), specifically the β-subunit (β-NGF), is an endogenous neurotrophin primarily involved in the survival, growth, and differentiation of neurons. It is produced in various tissues, including the nervous system and reproductive tracts of certain mammals. NGF belongs to the chemical class of proteins known as growth factors. Researchers have identified its presence in seminal plasma, where it plays a role in reproductive physiology. NGF is a critical factor in the development and maintenance of the peripheral nervous system and has been studied for its potential therapeutic applications in tissue repair and nerve regeneration. Researchers have observed that NGF facilitates sensory innervation, which is crucial for tissue regeneration and immunoregulation. It has been investigated for its role in ocular conditions, such as neurotrophic keratopathy and retinitis pigmentosa, and in reproductive biology, particularly in inducing ovulation in camelids and influencing luteal function in bovines. NGF exerts its effects primarily through binding to the TrkA receptor, initiating a cascade of intracellular signaling pathways that promote neuronal survival and differentiation. The p75NTR receptor also interacts with NGF, influencing mesenchymal stem cell functions. Pharmacokinetic data on NGF are limited, but topical and systemic applications have been explored in clinical settings. NGF's clinical use includes treatments for neurodegenerative diseases and certain eye conditions, with recombinant human NGF undergoing clinical trials. Regulatory approval varies by region, with ongoing research into its broader therapeutic potential.

Chemical profile

Chemische Struktur

Chemical structure of Nerve Growth Factor
FormelC11H19NO10
Molekulargewicht325.27g/mol
CAS-Nummer1113-83-3
PubChem CID60160600
Mechanism

Wirkmechanismus

NGF acts primarily through the TrkA receptor, triggering intracellular signaling pathways that promote neuronal survival, differentiation, and growth. It also interacts with the p75NTR receptor, influencing cell survival and differentiation processes.

Mechanism

Signalweg

Nerve Growth Factor (NGF) primarily exerts its effects through binding to two receptors: TrkA and p75NTR. Activation of TrkA initiates signaling cascades involving the PI3K/Akt and MAPK/ERK pathways, promoting neuronal survival, differentiation, and angiogenesis, while p75NTR is implicated in modulating cell survival and apoptosis. The precise mechanisms underlying NGF's role in mesenchymal stem/stromal cells (MSCs) and their interaction with other cell types remain incompletely understood.

Half-Life & Pharmacokinetics

ENEndogenous

Data limited

POOral

Poor bioavailability due to first-pass metabolism

Pharmacokinetic data specific to NGF administration routes are limited.

Storage

Temperature

Refrigerate at 2-8C

Light

Protect from light

Form

Aqueous solution: use within specified period after opening

Notes

Follow specific storage instructions provided with commercial formulations.

Solubility

Löslichkeit

NGF is generally soluble in aqueous solutions, relevant for its formulation in biological studies and therapeutic applications.

Legal Status

🇩🇪DE

Data limited

🇺🇸US

NGF is not scheduled by the DEA; FDA approval status varies by specific formulation and indication.

🇦🇺AU

Data limited

🇬🇧UK

Data limited

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

Open Questions

Offene Forschungsfragen

Current evidence is limited regarding the specific mechanisms by which nerve growth factor (NGF) influences mesenchymal stem/stromal cell (MSC) function, particularly in diverse populations and varying conditions. Further research is needed to clarify the contradictory findings related to NGF's role in reproductive physiology across different species, especially in bovines and equines, and to establish the long-term effects of NGF treatment in pediatric eye diseases through larger randomized controlled trials. Additionally, the potential therapeutic applications of NGF in enhancing tissue regeneration and immunoregulation require more extensive studies to determine optimal delivery methods and dosing strategies.

70 Research Publications

2,790

Total Citations

12

Human/RCT

4.0

Avg. Influence

2025

Latest

Sort
Filter
#01

Nerve growth factor and nociception.

In VitroInfluence19.0
545
Researchers observed that nerve growth factor is essential for the survival and phenotypic development of nociceptive sensory neurons, linking it to inflammation and hyperalgesia in adulthood.
#02

Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.

In VitroInfluence10.0
414
The study demonstrated that a heparin-containing fibrin matrix can control the release of beta-nerve growth factor, enhancing neurite extension in a cell culture model.
#03

Nerve Growth Factor and Pain Mechanisms.

Denk Franziska, et al. · Annual review of neuroscience · 2017

ReviewInfluence12.0
228
The study demonstrated that antagonism of nerve growth factor (NGF) may serve as a novel analgesic approach for conditions like osteoarthritis and lower back pain.

Key findings

  1. 01NGF antagonism shows promise as a pain relief treatment.
  2. 02There is still much to learn about NGF's role in persistent pain.
  3. 03Potential side effects of anti-NGF therapy need further investigation.
#04

Nerve Growth Factor: Early Studies and Recent Clinical Trials.

ReviewInfluence6.0
181
Researchers observed that nerve growth factor (NGF) has therapeutic potential in various human conditions, including skin and ocular diseases, based on extensive clinical studies.
#05

Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen.

AnimalInfluence1.0
122
Researchers observed that endogenous nerve growth factor expression in the rat caudate-putamen is temporally regulated and correlates with cholinergic neurochemical differentiation.
#06

beta-Nerve growth factor (beta NGF) receptors on glial cells. Cell-cell interaction between neurones and Schwann cells in cultures of chick sensory ganglia.

In Vitro
115
The study demonstrated that beta-nerve growth factor receptors are present on non-neuronal cells in chick sensory ganglia, indicating their role in neuron-Schwann cell interactions.
#07

Human beta-nerve growth factor gene sequence highly homologous to that of mouse.

In VitroInfluence2.0
89
Researchers observed that the human beta-nerve growth factor gene sequence is highly homologous to that of the mouse, indicating evolutionary conservation.
#08

Nerve growth factor (NGF) receptor expression in chicken cranial development.

In Vitro
82
Researchers observed specific binding of nerve growth factor receptors during chicken cranial development, indicating diverse roles in growth and differentiation of various tissues.
#09

Nerve growth factor beta(NGF beta) delivery via a collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone ingrowth.

Animal
80
The study demonstrated that nerve growth factor beta delivered via a collagen/hydroxyapatite composite enhances bone ingrowth and remodeling in craniofacial surgery.
#10

Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapies.

Zha Kangkang, et al. · Stem cells translational medicine · 2021

Review
56
Researchers observed that nerve growth factor (NGF) and its receptors significantly influence mesenchymal stem/stromal cell functions, including survival and differentiation.

Key findings

  1. 01NGF significantly impacts the survival and growth of MSCs.
  2. 02The receptor TrkA is primarily responsible for NGF's regulatory effects on MSCs.
  3. 03p75NTR is identified as a new surface marker for MSCs.

Clinical Trials (8)

Preclinical
Phase I
Phase II
Phase III
Approved

8

Total Trials

796

Total Enrolled

Assessment of the Effects of Extensive Somatosensory Training on Pain Processing

NCT04457466TERMINATED
Sponsor

Aalborg University

Enrollment

100

Started

2017

Primary outcome

Pain rating

Musculoskeletal Pain

Treatment of Cerebral Radiation Necrosis (CRN) With Nerve Growth Factor (NGF)

NCT02032147COMPLETED
Sponsor

Fudan University

Enrollment

30

Started

2009

Primary outcome

efficacy of using NGF for treating CRN

Cerebral NecrosisNashopharyngeal CancerNerve Growth Factor

Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease

NCT04041349Phase 4UNKNOWN
Sponsor

Zhujiang Hospital

Enrollment

50

Started

2019

Primary outcome

change of Alzheimer's disease assessment scale-cognition (ADAS-cog) score

Cerebral Small Vessel Diseases

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

NCT00000842Phase 2COMPLETED
Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment

270

HIV InfectionsPeripheral Nervous System Disease

An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye

NCT03019627Phase 2COMPLETED
Sponsor

Dompé Farmaceutici S.p.A

Enrollment

150

Started

2017

Primary outcome

Symptom Assessment in Dry Eye (SANDE) Scores

Dry Eye

Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury

NCT01212679Phase 2COMPLETED
Sponsor

Jinling Hospital, China

Enrollment

106

Started

2010

Primary outcome

improved neurological functions

Traumatic Brain Injury

Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma

NCT02855450Phase 1COMPLETED
Sponsor

Dompé Farmaceutici S.p.A

Enrollment

60

Started

2016

Primary outcome

Incidence of Events as of Primary Safety Outcomes

Glaucoma

Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

NCT03836859Phase 1COMPLETED
Sponsor

Dompé Farmaceutici S.p.A

Enrollment

30

Started

2018

Primary outcome

Number of Treatment Emergent Adverse Events (TEAEs).

Healthy Volunteers

Track your hormone research in PepStack

Log cycles, set reminders and visualize serum levels.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer